DeepLUCIA: predicting tissue-specific chromatin loops using Deep Learning-based Universal Chromatin Interaction Annotator.


Journal

Bioinformatics (Oxford, England)
ISSN: 1367-4811
Titre abrégé: Bioinformatics
Pays: England
ID NLM: 9808944

Informations de publication

Date de publication:
11 07 2022
Historique:
received: 21 12 2021
revised: 17 04 2022
accepted: 27 05 2022
pubmed: 1 6 2022
medline: 15 11 2022
entrez: 31 5 2022
Statut: ppublish

Résumé

The importance of chromatin loops in gene regulation is broadly accepted. There are mainly two approaches to predict chromatin loops: transcription factor (TF) binding-dependent approach and genomic variation-based approach. However, neither of these approaches provides an adequate understanding of gene regulation in human tissues. To address this issue, we developed a deep learning-based chromatin loop prediction model called Deep Learning-based Universal Chromatin Interaction Annotator (DeepLUCIA). Although DeepLUCIA does not use TF binding profile data which previous TF binding-dependent methods critically rely on, its prediction accuracies are comparable to those of the previous TF binding-dependent methods. More importantly, DeepLUCIA enables the tissue-specific chromatin loop predictions from tissue-specific epigenomes that cannot be handled by genomic variation-based approach. We demonstrated the utility of the DeepLUCIA by predicting several novel target genes of SNPs identified in genome-wide association studies targeting Brugada syndrome, COVID-19 severity and age-related macular degeneration. Availability and implementation DeepLUCIA is freely available at https://github.com/bcbl-kaist/DeepLUCIA. Supplementary data are available at Bioinformatics online.

Identifiants

pubmed: 35640981
pii: 6596048
doi: 10.1093/bioinformatics/btac373
doi:

Substances chimiques

Chromatin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3501-3512

Subventions

Organisme : National Research Foundation of Korea
Organisme : NRF
ID : NRF-2021M3H9A2097443
Organisme : The Ministry of Science and ICT

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Dongchan Yang (D)

Department of Bio and Brain Engineering, KAIST, Daejeon 34141, Republic of Korea.

Taesu Chung (T)

Biotechnology & Healthcare Examination Division, Convergence Technology Examination Bureau, KIPO, Daejeon 35208, Republic of Korea.

Dongsup Kim (D)

Department of Bio and Brain Engineering, KAIST, Daejeon 34141, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH